These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 38100670
21. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile. Hosseini A, Körber M, Bodmeier R. Int J Pharm; 2013 Dec 05; 457(2):503-9. PubMed ID: 23892153 [Abstract] [Full Text] [Related]
22. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach. Agrawal A, Dudhedia M, Deng W, Shepard K, Zhong L, Povilaitis E, Zimny E. AAPS PharmSciTech; 2016 Feb 05; 17(1):214-32. PubMed ID: 26757898 [Abstract] [Full Text] [Related]
23. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive. Nakamura S, Fukai T, Sakamoto T. AAPS PharmSciTech; 2021 Dec 23; 23(1):37. PubMed ID: 34950985 [Abstract] [Full Text] [Related]
24. Effect of a superdisintegrant on disintegration of orally disintegrating tablets determined by simulated wetting test and in vitrodisintegration test. Sutthapitaksakul L, Thanawuth K, Huanbutta K, Sriamornsak P. Pharmazie; 2022 Oct 01; 77(10):287-290. PubMed ID: 36273260 [Abstract] [Full Text] [Related]
25. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets. Devireddy SR, Gonugunta CS, Veerareddy PR. PDA J Pharm Sci Technol; 2009 Oct 01; 63(6):521-6. PubMed ID: 20169858 [Abstract] [Full Text] [Related]
26. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES. Amelian A, Szekalska M, Wilczewska AZ, Basa A, Winnicka K. Acta Pol Pharm; 2016 Oct 01; 73(2):453-60. PubMed ID: 27180438 [Abstract] [Full Text] [Related]
27. Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate. Ruslan MFH, Janakiraman AK, Ming LC, Uddin AH, Sarker ZI, Bin LK. Int J Pharm Compd; 2022 Oct 01; 26(2):155-162. PubMed ID: 35413014 [Abstract] [Full Text] [Related]
28. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Sheshala R, Khan N, Chitneni M, Darwis Y. Arch Pharm Res; 2011 Nov 01; 34(11):1945-56. PubMed ID: 22139694 [Abstract] [Full Text] [Related]
29. Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent. Koseki T, Onishi H, Takahashi Y, Uchida M, Machida Y. Chem Pharm Bull (Tokyo); 2008 Oct 01; 56(10):1384-8. PubMed ID: 18827375 [Abstract] [Full Text] [Related]
30. Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Shu T, Suzuki H, Hironaka K, Ito K. Chem Pharm Bull (Tokyo); 2002 Feb 01; 50(2):193-8. PubMed ID: 11848208 [Abstract] [Full Text] [Related]
31. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants. Goel H, Tiwary AK, Rana V. Acta Pol Pharm; 2011 Feb 01; 68(4):571-83. PubMed ID: 21796940 [Abstract] [Full Text] [Related]
32. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression. Obaidat AA, Obaidat RM. Acta Pharm; 2011 Mar 01; 61(1):83-91. PubMed ID: 21406346 [Abstract] [Full Text] [Related]
33. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration. Yang B, Wei C, Yang Y, Wang Q, Li S. Drug Dev Ind Pharm; 2018 Sep 01; 44(9):1417-1425. PubMed ID: 29557692 [Abstract] [Full Text] [Related]
34. [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method]. Kawano Y, Ito A, Sasatsu M, Machida Y, Onishi H. Yakugaku Zasshi; 2010 Dec 01; 130(12):1737-42. PubMed ID: 21139401 [Abstract] [Full Text] [Related]
35. Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms? Ohrem HL, Schornick E, Kalivoda A, Ognibene R. Pharm Dev Technol; 2014 May 01; 19(3):257-62. PubMed ID: 23528124 [Abstract] [Full Text] [Related]
36. Development of a multiparticulate drug delivery system for in situ amorphisation. Holm TP, Kokott M, Knopp MM, Boyd BJ, Berthelsen R, Quodbach J, Löbmann K. Eur J Pharm Biopharm; 2022 Nov 01; 180():170-180. PubMed ID: 36191869 [Abstract] [Full Text] [Related]
37. Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology. Zhang Y, Li Z, Tang H, Ren W, Gao X, Sun Y, Zhao QX, Wang F, Liu J. Drug Dev Ind Pharm; 2020 Jan 01; 46(1):42-49. PubMed ID: 31794271 [Abstract] [Full Text] [Related]
38. Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs). Woyna-Orlewicz K, Brniak W, Tatara W, Strzebońska M, Haznar-Garbacz D, Szafraniec-Szczęsny J, Antosik-Rogóż A, Wojteczko K, Strózik M, Kurek M, Jachowicz R, Mendyk A. Pharm Res; 2023 Dec 01; 40(12):2947-2962. PubMed ID: 37726407 [Abstract] [Full Text] [Related]
39. Taste Masking Study of Orally Disintegrating Film (ODF) Formulations Containing Memantine Hydrochloride. Gobal G, Phang HC, Ng ZQ, Loke YH, Chew YL, Uddin AH, Lee SK, Lakshminarayanan V, Liew KB, Rahman SA. Int J Pharm Compd; 2024 Dec 01; 28(5):402-407. PubMed ID: 39405568 [Abstract] [Full Text] [Related]
40. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride. Hu X, Li Y, Zhang E, Wang X, Xing M, Wang Q, Lei J, Huang H. AAPS PharmSciTech; 2013 Mar 01; 14(1):29-37. PubMed ID: 23180226 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]